Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$209 Hold
21
﹤0.01% 393
2022
Q3
$0 Hold
21
﹤0.01% 499
2022
Q2
$1K Hold
21
﹤0.01% 412
2022
Q1
$1K Hold
21
﹤0.01% 392
2021
Q4
$1K Hold
21
﹤0.01% 350
2021
Q3
$1K Buy
21
+20
+2,000% +$794 ﹤0.01% 342
2021
Q2
$0 Buy
+1
New +$34 ﹤0.01% 412

Other funds holding XPEV

Burleson & Co's XPEV Position: Q4 2022 in Review

Burleson & Co held its XPeng (XPEV) position steady in Q4 2022 at 21 shares worth $209. The position accounts for ﹤0.01% of the portfolio, ranked #393.

Burleson & Co first reported a position in XPEV in Q2 2021 and has held it in 7 quarters since. The position peaked at $1K in Q2 2022. 229 funds tracked by Wall St. Rank hold XPEV as of Q4 2022.

  • Burleson & Co held 21 shares of XPeng worth $209 as of Q4 2022.
  • Burleson & Co left its XPeng share count unchanged in Q4 2022.
  • XPeng made up ﹤0.01% of Burleson & Co's portfolio in Q4 2022, its #393 holding.
  • Burleson & Co first reported a position in XPeng in Q2 2021 and has held it in 7 quarters since.
  • Burleson & Co's XPeng position peaked at $1K in Q2 2022.
  • 229 funds tracked by Wall St. Rank held XPeng as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.